Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin Dosing and Platelet Phenotype in Pregnancy
NCT07525635Phase 1Recruiting
- Sponsor
- NYU Langone Health
- Start
- Apr 2026
- Primary completion
- Aug 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of aspirin in preeclampsia, sponsored by NYU Langone Health. Primary endpoint: Measures of platelet aggregation assessed by Light Transmission Aggregometry (LTA) at 4 weeks. Started Apr 2026; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT07525635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07525635.